Researchers continue to excited about the medication , a groundbreaking dual agonist showing promising results in early trials for weight loss . It acts by modulating several systems: GLP-1 and GIP, these, when activated , support regulate cravings and improve energy expenditure . Initial findings demonstrate substantial body reduction and likely b